PD?PSP?MSA?SCA?CBD
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects had already undergone 18F-FDG PET at our hospital, and some of them also had 18F-DOPA PET data available. 2.A definite diagnosis was made by neurologists according to established clinical diagnostic criteria and documented in the medical records, including PD, PSP, MSA, SCA, and CBD. 3.Basic clinical information required for research analysis was available, including at least age, sex, and diagnostic category. 4.The PET image quality met the requirements for analysis.
Exclusion criteria
Exclusion criteria: 1.Subjects with other conditions that might significantly affect brain metabolism were excluded, including active central nervous system infection, significant sequelae of stroke, brain tumors, severe sequelae of traumatic brain injury; 2. CT shows obvious structural abnormalities that may severely interfere with metabolic analysis (such as large-area infarction, mass effect, hemorrhage, etc.); 3. PET images have obvious artifacts (such as significant head movement, reconstruction failure, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SUVR; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gender;Age; | — |
Countries
China
Contacts
Beijing Chao-Yang Hospital, Capital Medical University